Henkel found buyers for Russian assets

Henkel is in the final stages of the sale of its Russian assets. This was reported to Vedomosti by its representative. He declined to name the buyer, saying only that “an agreement between the parties has not yet been signed.” A source familiar with the details of the transaction assures that 11 factories of the German company can be acquired by a consortium of investors, which includes shareholders of the drug manufacturer Pharmstandard (owned by Viktor Kharitonin and Yegor Kulkov), Kismet Capital investment company Ivan Tavrin, as well as the founders of the Elbrus fund capital”. This information was confirmed by a source close to the firm, which also considered the purchase of these assets, as well as one of the real estate consultants.

Two interlocutors of Vedomosti claim that the shareholders of Pharmstandard will become the majority owners of Henkel’s Russian enterprises. According to them, the parties have already received permission from the government commission to conclude a deal. One of them knows that the agreement will include a buyback option for the plants. The interlocutors of Vedomosti assure that after the sale of the factories they will continue to produce products under the Henkel brands. They did not disclose the amount of the deal.